Ymmunobio
- Biotech or pharma, therapeutic R&D
Ymmunobio is a pre-clinical stage Biotech company focusing on first in class solid tumor treatments. Their novel target has superior properties (highest prevalence, large presence and not expressed in normal tissue).
PoC with ADCs in vivo demonstrated.



